Discovery and characterization of new bacterial cell division genes
Discovery and characterization of new bacterial cell division genes
批准号:
7786957
负责人:
DAVID S WEISS
金额:
$30.63万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-03-16 至 2013-02-28
关键词:
Amino AcidsAnimal ModelAntibioticsBacteriaBindingBinding SitesBiochemicalBiochemistryBiological AssayCalorimetryCell divisionCellsCleaved cellCollectionCommunitiesComplexCytoplasmic TailDevelopmentEnsureEscherichia coliFutureGenesGoalsKnowledgeLeadMediatingMembraneMetabolismMethodsModelingPeptidoglycanPhenotypePlayPolysaccharidesProteinsPublic HealthRoleSignal TransductionSiteSite-Directed MutagenesisSolutionsStructureSystemTertiary Protein StructureTestingTitrationsTransmission Electron Microscopybasecell envelopeconstrictiondesignfollow-upimprovedin vivoinsightmutantnovelprotein protein interactionprotein structurepublic health relevanceresearch studystructural biologyyeast two hybrid system
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The long-term goal of these studies is to better understand cell division in the model organism Escherichia coli. A deeper understanding of bacterial cell division is expected to facilitate the development of new antibiotics and will therefore benefit public health. In E. coli, cell division is mediated by a structure called the "septal ring," which is known to contain about 20 proteins. An important challenge for the future will be to identify and characterize any proteins that are missing from the current model. The experiments proposed here concern three newly discovered E. coli septal ring proteins that carry a peptidoglycan binding domain known as a SPOR domain. Specific Aim1 will explore the roles of the SPOR domain proteins during constriction. Specific Aims 2 and 3 are based on the observation that the SPOR domains themselves localize to the division site. This implies that SPOR domains bind preferentially to septal peptidoglycan. Aim 2 explores structural features of peptidoglycan that are recognized by SPOR domains. Aim 3 defines the structure of the peptidoglycan binding site on a SPOR domain. Understanding how SPOR domains specifically target septal peptidoglycan might provide important insights into septal peptidoglycan synthesis. PUBLIC HEALTH RELEVANCE: The studies proposed here will lead to a greater understanding of bacterial cell division. That knowledge can be used to develop new antibiotics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Heteroresistance Interdisciplinary Research Unit (Project 2)
-
批准号:10366038
-
项目类别:
-
资助金额:$35.85万
-
财政年份:2021
-
负责人:DAVID S WEISS
-
依托单位:
CRISPR interference-enabled phenotyping of essential genes in C. difficile to aid in discovery of antibiotic targets
-
批准号:10369416
-
项目类别:
-
资助金额:$20.86万
-
财政年份:2021
-
负责人:DAVID S WEISS
-
依托单位:
CRISPR interference-enabled phenotyping of essential genes in C. difficile to aid in discovery of antibiotic targets
-
批准号:10518406
-
项目类别:
-
资助金额:$17.38万
-
财政年份:2021
-
负责人:DAVID S WEISS
-
依托单位:
Heteroresistance Interdisciplinary Research Unit (Project 2)
-
批准号:10583505
-
项目类别:
-
资助金额:$55.09万
-
财政年份:2021
-
负责人:DAVID S WEISS
-
依托单位:
Heteroresistance Interdisciplinary Research Unit (Project 2)
-
批准号:10170971
-
项目类别:
-
资助金额:$56.46万
-
财政年份:2021
-
负责人:DAVID S WEISS
-
依托单位:
Heteroresistance Interdisciplinary Research Unit (Admin Core)
-
批准号:10170967
-
项目类别:
-
资助金额:$19.99万
-
财政年份:2021
-
负责人:DAVID S WEISS
-
依托单位:
Heteroresistance Interdisciplinary Research Unit (Admin Core)
-
批准号:10583498
-
项目类别:
-
资助金额:$30.66万
-
财政年份:2021
-
负责人:DAVID S WEISS
-
依托单位:
Heteroresistance Interdisciplinary Research Unit (Admin Core)
-
批准号:10366034
-
项目类别:
-
资助金额:$35.85万
-
财政年份:2021
-
负责人:DAVID S WEISS
-
依托单位:
Exploitation of multiple heteroresistance for effective antibiotic combination therapy
-
批准号:10646392
-
项目类别:
-
资助金额:$80.37万
-
财政年份:2020
-
负责人:DAVID S WEISS
-
依托单位:
Exploitation of multiple heteroresistance for effective antibiotic combination therapy
-
批准号:10206015
-
项目类别:
-
资助金额:$80.37万
-
财政年份:2020
-
负责人:DAVID S WEISS
-
依托单位:
Exploitation of multiple heteroresistance for effective antibiotic combination therapy
-
批准号:10053046
-
项目类别:
-
资助金额:$82.33万
-
财政年份:2020
-
负责人:DAVID S WEISS
-
依托单位:
Exploitation of multiple heteroresistance for effective antibiotic combination therapy
-
批准号:10433990
-
项目类别:
-
资助金额:$80.37万
-
财政年份:2020
-
负责人:DAVID S WEISS
-
依托单位:
Mechanisms of phenotypic antibiotic resistance in Gram-negative bacteria
-
批准号:9790937
-
项目类别:
-
资助金额:$43.68万
-
财政年份:2018
-
负责人:DAVID S WEISS
-
依托单位:
Mechanisms of phenotypic antibiotic resistance in Gram-negative bacteria
-
批准号:10242729
-
项目类别:
-
资助金额:$43.47万
-
财政年份:2018
-
负责人:DAVID S WEISS
-
依托单位:
Peptidoglycan binding protein specificity and bacterial cell division
-
批准号:10015285
-
项目类别:
-
资助金额:$32.88万
-
财政年份:2018
-
负责人:DAVID S WEISS
-
依托单位:
Peptidoglycan binding protein specificity and bacterial cell division
-
批准号:10246987
-
项目类别:
-
资助金额:$32.88万
-
财政年份:2018
-
负责人:DAVID S WEISS
-
依托单位:
Molecular mechanisms of antibiotic resistance in Acinetobacter baumannii
-
批准号:9205452
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:DAVID S WEISS
-
依托单位:
CRISPR/Cas systems in bacterial gene regulation and virulence
-
批准号:8671666
-
项目类别:
-
资助金额:$44.17万
-
财政年份:2014
-
负责人:DAVID S WEISS
-
依托单位:
CRISPR/Cas systems in bacterial gene regulation and virulence
-
批准号:8793757
-
项目类别:
-
资助金额:$44.12万
-
财政年份:2014
-
负责人:DAVID S WEISS
-
依托单位:
Molecular Characterization of Francisella tularensis SchuS4 virulence factors
-
批准号:8375877
-
项目类别:
-
资助金额:$39.09万
-
财政年份:2012
-
负责人:DAVID S WEISS
-
依托单位:
海外基金